STUDY OF PHARMACEUTICAL PROVISION OF TYPE 2 DIABETES THERAPY IN UKRAINE

Authors

DOI:

https://doi.org/10.11603/2312-0967.2022.2.13332

Keywords:

diabetes, guidelines for the treatment of type 2 diabetes, glucose-lowering drugs, assortment, availability

Abstract

The aim of the work. Analysis of Legislation and guidelines of pharmaceutical providing of type 2 diabetes (T2D) patients in Ukraine and studying of the availability of the glucose-lowering drugs (GLD) for the treatment of this disease according to guidelines.

Materials and Methods. The objects of the study were domestic and foreign clinical guidelines on T2D therapy, the State Register of Medicines of Ukraine. Bibliosemantic, marketing, analytical, graphic, generalization analyses were used.

Results and Discussion. The current legislation of Ukraine allows doctors to use modern international clinical guidelines for the treatment of DM, while the Unified Clinical Protocol for T2D approved by the Ministry of Health of Ukraine in 2012 remains in force. On the pharmaceutical market of Ukraine, 161 GLDs are registered, which contain 16 INN names. Out of 27 existing INN combinations on the world market, 8 INN combinations are registered in Ukraine. The largest part (64.0 %) of the range of GLD registered in Ukraine is supplied by foreign manufacturers. Part of the registered assortment of GLD in pharmacies is absent.

Conclusion. A comparative analysis of the guidelines showed that the Unified Clinical Protocol T2D needed updating. The study showed that in Ukraine, a sufficient range of GLD was registered, which allows the use of modern schemes for the treatment of diabetes, according to the international guidelines.

Author Biographies

I. O. Vlasenko, Shupyk National Healthcare University of Ukraine

PhD (Pharmacy), Associate Professor, Pharmaceutical Technology and Biopharmaceuticals Department

L. L. Davtian, Shupyk National Healthcare University of Ukraine

DSc (Pharmacy), Professor, Head of the Pharmaceutical Technology and Biopharmaceuticals Department

O. M. Zaliska, Danylo Halytsky Lviv National Medical University

DSc (Pharmacy), Professor, Head of the Department of Management and Economy, Drug Technology and Pharmacoeconomics of Postgraduate Faculty

References

International diabetes federation Diabetes Atlas 9th edition. URL: http://www. diabetesatlas.org

DeFronzo RA, Ferrannini E, Zimmet P, Alberti G. International Textbook of Diabetes Mellitus, 2 Vol., 4th Edition; 2015.

Sholoiko N, Gonchar A. [Comparative analysis of the range list of medicines for the treatment of arterial hypertension in accordance with domestic and international clinical guidelines]. Farmats Zhurn. 2022;1:31-39. Ukrainian.

Chumak I. [Intensification of type 2 diabetes therapy in accordance with modern recommendations]. Diabetolohiia, Tyreoidolohiia, Metabolichni rozlady. 2021;1(53): 22-3. Ukrainian.

Unified clinical protocol of primary and secondary (specialized) medical care type 2 diabetes mellitus]. URL: https://www.dec.gov.ua/wp-content/uploads/2019/11/2012_1118ykpmd.pdf Ukrainian.

Oder No. 1422, 29.12.2016, Ministry of Health of Ukraine. About making changes to the order of the Ministry of Health of Ukraine 28.09.2012 N751 URL: http://search.ligazakon.ua/l_doc2.nsf/link1/RE30398Z.html. Ukrainian.

American Diabetes Association. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes Care 2022;45(1): S125-43

Pharmacologic Glycemic Management of Type 2 Diabetes in Adults: 2020 Diabetes Canada Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. URL: https://guidelines.diabetes.ca/cpg/chapter-13-2020-update.

The Royal Australian College of General Practitioners. Management of type 2 diabetes: A handbook for general practice. East Melbourne, Vic: RACGP, 2020. URL: https://www.racgp.org.au/getattachment/41fee8dc-7f97-4f87-9d90-b7af337af778/Management-of-type-2-diabetes-A-handbook-for-general-practice.aspx

National Institute for Health and Care Excellence (Great Britan) Type 2 diabetes in adults: choosing first-line medicines. URL: https://www.nice.org.uk/guidance/ng28/resources/visual-summary-short-version-choosing-medicines-for-firstline-treatment-pdf-10956472094

International Diabetes Federation. Global Guideline for Type 2 diabetes. URL: https://www.iapb.org/wp-content/uploads/Global-Guideline-for-Type-2-Diabetes-IDF-2012.pdf

International Diabetes Federation. Managing older people with Type 2 Diabetes. Global Guideline. Brussels: IDF; 2013.

IDF Clinical Practice Recommendations for managing Type 2 Diabetes in Primary Care. URL: https://www.idf.org/e-library/guidelines/128-idf-clinical-practice-recommendations-for-managing-type-2-diabetes-in-primary-care.html

Diagnosis and management of type 2 diabetes (HEARTS-D). Geneva]: WHO; 2020. URL: https://apps.who.int/iris/bitstream/handle/10665/272433/9789241550284-eng.pdf?sequence=1&isAllowed=y

Guidelines on second- and third-line medicines and type of insulin for the control of blood glucose levels in non-pregnant adults with diabetes mellitus. Geneva: WHO; 2018. URL: http://apps.who.int/iris/bitstream/handle/10665/272433/9789241550284-eng.pdf?ua=1)

American Diabetes Association. Standards of Medical Care in Diabetes 2021. URL: https://doi.org/10.2337/dc21

ATC/DDD Index 2022. URL: https://www.whocc.no/atc_ddd_index

Nemchenko A, Nazarkyna V. [Improvement of modern approaches to reference pricing for insulin preparations]. Farmats zhurn. 2020;5: 23-33. Ukrainian.

Vlasenko I, Davtian L. [Pharmaceutical supply of insulin preparations in Ukraine for 2016–2021]. Farmats chasopys. 2021;2: 55-64. Ukrainian.

Assessment of the availability of basic medicines for outpatient treatment in Ukraine. Copenhagen: WHO European region; 2021. Ukrainian.

Luo F, Das A, Chen J. Metformin in patients with and without diabetes: a paradigm shift in cardiovascular disease management. Cardiovasc Diabetol. 2019;18.

Savych AO, Pavliuk BV. Marketing analysis of the pharmaceutical market of antidiabetic drugs in Ukraine Current issues in pharmacy and medicine: science and practice 2022;15(1): 80-5.

Vlasenko IO, Davtian LL. [Audit of prepackaged products of medicinal plants used for diabetes on the pharmaceutical market of Ukraine]. Fitoterapiia. Chasopys. 2021;3: 53-61.

Downloads

Published

2022-12-02

How to Cite

Vlasenko, I. O., Davtian, L. L., & Zaliska, O. M. (2022). STUDY OF PHARMACEUTICAL PROVISION OF TYPE 2 DIABETES THERAPY IN UKRAINE. Pharmaceutical Review Farmacevtičnij časopis, (2), 12–20. https://doi.org/10.11603/2312-0967.2022.2.13332

Issue

No. 2 (2022)

Section

Pharmaceutical management, marketing and logistics

License

Copyright (c) 2022 Pharmaceutical Review / Farmacevtičnij časopis

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

The authors who publish their materials in this journal agree with the following terms:

  • Authors reserve the right to authorship of their work and assign to the journal the right to first publish this work under the terms of the Creative Commons Attribution License, which allows other persons to freely distribute the published work with a mandatory reference to the authors of original work and the first publication of work in this journal Результат пошуку зображень за запитом "CC-BY logo".
  • Authors have the right to make independent extra-exclusive work agreements in the form they are published by this journal (for example, posting work in an electronic repository of an institution or publishing as part of a monograph), provided that the link to the first publication of the work in this journal is maintained.

Journal policy allows and encourages publication of manuscripts on the Internet (for example, in institutions repositories or on personal websites), both before the publication of this manuscript and during its editorial review, as it contributes to productive scientific discussion and positively affects the efficiency and dynamics of the citation of the published work (see The Effect of Open Access).